About Pharma Test Instruments India Private Limited
Data last updated:
Pharma Test Instruments India Private Limited is a foreign private limited company based in Hyderabad, Telangana, India, a subsidiary of Pharma Test Apparatebau Ag. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 28 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U29219TG2011FTC124916. Its GSTIN is 36AAFCP9346J1ZX (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹49.9 Lakh. It is led by directors including Chandrakanth Neelam and Shiva Chetana Neelam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.75 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹11.19 Lakh (net margin 6.4%) and EBITDA of ₹21.21 Lakh (EBITDA margin 12.1%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharma-test.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressD.No.6 – 1484/P&1485/P First Floor Puppala Pride Bdg Lahari Est. Opp. Axis Bank Pragathi Naga, R, Hyderabad, Telangana, India – 500090
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pharma Test Instruments India Private Limited
The main business activities of Pharma Test Instruments India are professional, scientific and technical and trade. In detail, this covers advertising and market research, architecture, engineering activities, technical testing and analysis activities and retail trading. 3 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M6 | Advertising and market research | Locked |
| M | Professional, Scientific and Technical | M4 | Architecture, engineering activities, technical testing and analysis activities | Locked |
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pharma Test Instruments India Private Limited FY 2025 filings available
Pharma Test Instruments India Private Limited reported revenue of ₹1.75 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Pharma Test Instruments India Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 16% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pharma Test Instruments India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹21.21 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹11.19 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pharma Test Instruments India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pharma Test Instruments India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Pharma Test Instruments India Private Limited
Pharma Test Instruments India Private Limited is audited by R P S V & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R P S V & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pharma Test Instruments India Private Limited
Pharma Test Instruments India has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrakanth Neelam | Director | 05 Nov 2014 | 11 Years 11 Months | Current |
| Shiva Chetana Neelam | Director | 05 Nov 2014 | 11 Years 11 Months | Current |
| Bjoern Faehler | Director | 03 Oct 2011 | 15 Years 0 Months | Current |
Ownership and Shareholding of Pharma Test Instruments India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pharma Test Instruments India Private Limited
Pharma Test Instruments India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Pharma Test Instruments India Private Limited
Employment history and EPFO contributions of people linked to Pharma Test Instruments India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Pharma Test Instruments India Private Limited
Pharma Test Instruments India has one previous CIN (Corporate Identification Number): U29219KA2011FTC057874. The current CIN is U29219TG2011FTC124916, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U29219TG2011FTC124916 | Current |
| U29219KA2011FTC057874 | Previous |
Recent Activity on Pharma Test Instruments India Private Limited
Pharma Test Instruments India Private Limited has 10 board changes on record since 2011: 3 appointments and 7 cessations. The latest: Chandrakanth Neelam ceased to be Additional Director on 28 Sep 2015.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Pharma Test Instruments India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pharma Test Instruments India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pharma Test Instruments India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pharma Test Instruments India Private Limited
Pharma Test Instruments India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCP9346J1ZX | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pharma Test Instruments India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharma Test Instruments India Private Limited
Pharma Test Instruments India is an active foreign private limited company based in Hyderabad, Telangana, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 28 March 2011 (15+ years old) and is registered under CIN U29219TG2011FTC124916.
Pharma Test Instruments India reported revenue of ₹1.75 Cr for FY 2025 (up 16% YoY).
Pharma Test Instruments India has 3 current directors:
- Chandrakanth Neelam - Director
- Shiva Chetana Neelam - Director
- Bjoern Faehler - Director
Pharma Test Instruments India reported a net profit of ₹11.19 Lakh (net margin 6.4%) and EBITDA of ₹21.21 Lakh (EBITDA margin 12.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pharma Test Instruments India is 17% over three years and 13% over five years. In the latest year (FY 2025) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pharma Test Instruments India is 36AAFCP9346J1ZX, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Pharma Test Instruments India is U29219TG2011FTC124916. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharma Test Instruments India was incorporated on 28 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Chandrakanth Neelam ceased to be Additional Director on 28 Sep 2015. Shiva Chetana Neelam ceased to be Additional Director on 28 Sep 2015. Praveen Singhal ceased to be Director on 14 Jan 2015. Pharma Test Instruments India has 10 board changes on record in total.
Pharma Test Instruments India can be reached through the website pharma-test.in. Its registered office is in Hyderabad, Telangana, India.